{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:16:46Z","timestamp":1787613406100,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,2]]},"DOI":"10.7759\/cureus.81622","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T22:43:21Z","timestamp":1743633801000},"source":"Crossref","is-referenced-by-count":1,"title":["The Optimal Timing for Initiating Anamorelin in the Treatment of Cancer Cachexia"],"prefix":"10.7759","author":[{"given":"Miki","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeri","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Umeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Mastumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon K","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al.. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 2011, 12:489-95. 10.1016\/s1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s JM","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer. 2014, 14:754-62. 10.1038\/nrc3829","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12391","article-title":"Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study","volume":"10","author":"da Rocha IM","year":"2019","unstructured":"da Rocha IM, Marcadenti A, de Medeiros GO, Bezerra RA, Rego JF, Gonzalez MC, Fayh AP. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study. J Cachexia Sarcopenia Muscle. 2019, 10:445-54. 10.1002\/jcsm.12391","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato PE","year":"2016","unstructured":"Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016, 5:e200. 10.1038\/oncsis.2016.3","journal-title":"Oncogenesis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2019-002176","article-title":"Cachexia is associated with depression, anxiety and quality of life in cancer patients","volume":"13","author":"Sun H","year":"2023","unstructured":"Sun H, Sudip T, Fu X, Wen S, Liu H, Yu S. Cachexia is associated with depression, anxiety and quality of life in cancer patients. BMJ Support Palliat Care. 2023, 13:e129-35. 10.1136\/bmjspcare-2019-002176","journal-title":"BMJ Support Palliat Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami N","year":"2018","unstructured":"Katakami N, Uchino J, Yokoyama T, et al.. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer. 2018, 124:606-16. 10.1002\/cncr.31128","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi S","year":"2019","unstructured":"Hamauchi S, Furuse J, Takano T, et al.. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer. 2019, 125:4294-302. 10.1002\/cncr.32406","journal-title":"Cancer"},{"key":"ref8","article-title":"[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]","volume":"85","author":"Onodera T","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984, 85:1001-5.","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08097-4","article-title":"Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia","volume":"31","author":"Tsukiyama I","year":"2023","unstructured":"Tsukiyama I, Iwata T, Takeuchi T, et al.. Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia. Support Care Cancer. 2023, 31:621. 10.1007\/s00520-023-08097-4","journal-title":"Support Care Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665108007131","article-title":"An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer","volume":"67","author":"McMillan DC","year":"2008","unstructured":"McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008, 67:257-62. 10.1017\/S0029665108007131","journal-title":"Proc Nutr Soc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32832a7902","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer","volume":"12","author":"McMillan DC","year":"2009","unstructured":"McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009, 12:223-6. 10.1097\/MCO.0b013e32832a7902","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.11.007","article-title":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score","volume":"40","author":"Douglas E","year":"2014","unstructured":"Douglas E, McMillan DC. Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score. Cancer Treat Rev. 2014, 40:685-91. 10.1016\/j.ctrv.2013.11.007","journal-title":"Cancer Treat Rev"},{"key":"ref13","article-title":"[Web Questionnaire Survey on Appetite Loss and Weight Loss Associated With Cancer Cachexia Japanese Evidence for Patients of Cancer Cachexia (J-EPOCC)-The Understanding of Cancer Cachexia]","volume":"47","author":"Morimoto T","year":"2020","unstructured":"Morimoto T, Machii K, Matsumoto H, Takai S. [Web Questionnaire Survey on Appetite Loss and Weight Loss Associated With Cancer Cachexia Japanese Evidence for Patients of Cancer Cachexia (J-EPOCC)-The Understanding of Cancer Cachexia]. Gan To Kagaku Ryoho. 2020, 47:1075-80.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref14","article-title":"[The Second Web Questionnaire Survey on Cancer Cachexia: Japanese Evidence for Patients of Cancer Cachexia II(J-EPOCC\u2161)-Challenges in Early Detection and Early Intervention for Appetite Loss and Weight Loss During Cancer Treatment]","volume":"51","author":"Kiguchi M","year":"2024","unstructured":"Kiguchi M, Kanemata S, Machii K, Doi I, Kinoshita F. [The Second Web Questionnaire Survey on Cancer Cachexia: Japanese Evidence for Patients of Cancer Cachexia II(J-EPOCC\u2161)-Challenges in Early Detection and Early Intervention for Appetite Loss and Weight Loss During Cancer Treatment]. Gan To Kagaku Ryoho. 2024, 51:159-65.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13105","article-title":"Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps","volume":"13","author":"Baracos VE","year":"2022","unstructured":"Baracos VE, Coats AJ, Anker SD, Sherman L, Klompenhouwer T. Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps. J Cachexia Sarcopenia Muscle. 2022, 13:2683-96. 10.1002\/jcsm.13105","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-85","article-title":"The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer","volume":"8","author":"Kemik O","year":"2010","unstructured":"Kemik O, Sumer A, Kemik AS, et al.. The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol. 2010, 8:85. 10.1186\/1477-7819-8-85","journal-title":"World J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0960327111417271","article-title":"The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic","volume":"31","author":"Kemik O","year":"2012","unstructured":"Kemik O, Kemik AS, Begenik H, et al.. The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic. Hum Exp Toxicol. 2012, 31:117-25. 10.1177\/0960327111417271","journal-title":"Hum Exp Toxicol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/j.pbj.0000000000000123","article-title":"Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia","volume":"6","author":"Tavares P","year":"2021","unstructured":"Tavares P, Gon\u00e7alves DM, Santos LL, Ferreira R. Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia. Porto Biomed J. 2021, 6:e123. 10.1097\/j.pbj.0000000000000123","journal-title":"Porto Biomed J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0730-22","article-title":"Impact of the extent of weight loss before administration on the efficacy of anamorelin in advanced pancreatic cancer patients with cachexia","volume":"62","author":"Takeda T","year":"2023","unstructured":"Takeda T, Sasaki T, Okamoto T, et al.. Impact of the extent of weight loss before administration on the efficacy of anamorelin in advanced pancreatic cancer patients with cachexia. Intern Med. 2023, 62:1887-93. 10.2169\/internalmedicine.0730-22","journal-title":"Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08206-3","article-title":"Systemic inflammation adversely affects response to anamorelin in patients with pancreatic cancer","volume":"31","author":"Tsunematsu M","year":"2023","unstructured":"Tsunematsu M, Uwagawa T, Onda S, et al.. Systemic inflammation adversely affects response to anamorelin in patients with pancreatic cancer. Support Care Cancer. 2023, 31:732. 10.1007\/s00520-023-08206-3","journal-title":"Support Care Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07576-y","article-title":"Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: A retrospective study","volume":"31","author":"Iwai N","year":"2023","unstructured":"Iwai N, Sakai H, Oka K, et al.. Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: A retrospective study. Support Care Cancer. 2023, 31:115. 10.1007\/s00520-023-07576-y","journal-title":"Support Care Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77795","article-title":"Significance of neutrophil-to-lymphocyte ratio in predicting the efficacy of anamorelin for cancer cachexia","volume":"17","author":"Nakazawa Y","year":"2025","unstructured":"Nakazawa Y, Watanabe K, Gannichida A, Uwagawa T, Kawakubo T. Significance of neutrophil-to-lymphocyte ratio in predicting the efficacy of anamorelin for cancer cachexia. Cureus. 2025, 17:e77795. 10.7759\/cureus.77795","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/349011-the-optimal-timing-for-initiating-anamorelin-in-the-treatment-of-cancer-cachexia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T22:43:33Z","timestamp":1743633813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/349011-the-optimal-timing-for-initiating-anamorelin-in-the-treatment-of-cancer-cachexia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.81622","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,2]]}}}